Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verdugo, R. J.
Right arrow Articles by Ochoa, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verdugo, R. J.
Right arrow Articles by Ochoa, J. L.
NEUROLOGY 1994;44:1003
© 1994 American Academy of Neurology

‘Sympathetically maintained pain’

I. Phentolamine block questions the concept

Renato J. Verdugo, MD, MSc and José L. Ochoa, MD, PhD, DSc

Departments of Neurology and Neurosurgery, Good Samaritan Hospital and Oregon Health Sciences University, Portland, OR.

Patients with "reflex sympathetic dystrophy" or "causalgia" underwent sympathetic blocks. In protocol A (77 patients), we infused placebo (saline) for 30 minutes followed by phentolamine (35 mg). In protocol B (23 patients), the saline phase was followed by double-blind infusion of phentolamine or phenylephrine (500 µg), a second phase of saline, and then the other active drug. We assessed magnitudes of pain and mechanical hyperalgesias on a 0-to-10 pain scale and monitored sensory and sympathetic effects. With protocol A, pain diminished significantly (≥ 50%) during placebo in 22 patients (28.9%) and during phentolamine in seven (9.2%). With protocol B, four patients (17.3%) had relief of pain during placebo, four (17.3%) during phenylephrine, and two (8.7%) during phentolamine. All "phentolamine responders" had progressive pain relief from placebo. Two patients expressed relief during phenylephrine and worsening during phentolamine. Most patients did not respond significantly to saline or drugs. Thus, pharmacologica manipulation of the alpha-1 adrenergic receptor by either agonist or antagonist drug does not influence neuropathic pains. These results raise questions about the existence of "sympathetically maintained pain," as diagnosed by sympathetic blocks improperly controlled for placebo.

Address correspondence and reprint requests to Dr. José L. Ochoa, Neuromuscular Unit, Department of Neurology, Good Samaritan Hospital and Medical Center, 1040 N.W. 22nd Avenue, Suite 460, Portland, OR 97210.

Supported by NIH grants ROI NS, 24740, 24766, and 28747.

Received August 13, 1993. Accepted for publication in final form December 9, 1993.




This article has been cited by other articles:


Home page
J. Physiol.Home page
G. Lambert, M. Elam, P. Friberg, C. Lundborg, S. Gao, J. Bergquist, and P. Nitescu
Acute response to intracisternal bupivacaine in patients with refractory pain of the head and neck
J. Physiol., January 15, 2006; 570(2): 421 - 428.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Schrag, M. Trimble, N. Quinn, and K. Bhatia
The syndrome of fixed dystonia: an evaluation of 103 patients
Brain, October 1, 2004; 127(10): 2360 - 2372.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. D. Drummond, P. M. Finch, S. Skipworth, and P. Blockey
Pain increases during sympathetic arousal in patients with complex regional pain syndrome
Neurology, October 9, 2001; 57(7): 1296 - 1303.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. H. Hord, D. D. Denson, B. Stowe, and R. M. Haygood
{{alpha}}-1 and {{alpha}}-2 Adrenergic Antagonists Relieve Thermal Hyperalgesia in Experimental Mononeuropathy from Chronic Constriction Injury
Anesth. Analg., June 1, 2001; 92(6): 1558 - 1562.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Elam, B. Olausson, J. O. Skarphedinsson1, and B. G. Wallin
Does sympathetic nerve discharge affect the firing of polymodal C-fibre afferents in humans?
Brain, December 1, 1999; 122(12): 2237 - 2244.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. Baron, G. Wasner, R. Borgstedt, E. Hastedt, H. Schulte, A. Binder, F. Kopper, M. Rowbotham, J. D. Levine, and H. L. Fields
Effect of sympathetic activity on capsaicin-evoked pain, hyperalgesia, and vasodilatation
Neurology, March 1, 1999; 52(5): 923 - 923.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
H. Nukada, A. M. van Rij, S. G. K. Packer, A. Patterson, and H. Nukada
Preservation of Skin Vasoconstrictor Responses in Chronic Atherosclerotic Peripheral Vascular Disease
Angiology, March 1, 1998; 49(3): 181 - 188.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
M. Liu, M. B. Max, S. Parada, J. S. Rowan, and G. J. Bennett
The Sympathetic Nervous System Contributes to Capsaicin-Evoked Mechanical Allodynia But Not Pinprick Hyperalgesia in Humans
J. Neurosci., November 15, 1996; 16(22): 7331 - 7335.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J.L. Ochoa and E.T. Hedley-Whyte
Case 38-1995- A 68-year-old man with paresthesias and severe pain in both hands
N. Engl. J. Med., December 14, 1995; 333(24): 1625 - 1630.
[Full Text] [PDF]


Home page
Neurorehabil Neural RepairHome page
S. Hesse, M.T. Jahnke, R. Ehret, and K.H. Mauritz
Shoulder-Hand Syndrome in Hemiplegic Patients: Temperature, Sympathetic Skin Responses, and Nerve Latencies of the Affected and Nonaffected Upper Extremity
Neurorehabil Neural Repair, January 1, 1995; 9(4): 229 - 233.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by AAN Enterprises, Inc.